Clinical trial · Observational
Study on Plasmablastic Lymphoma Patients
An International Multicenter Observational Retrospective Study on Plasmablastic Lymphoma Patients
NCT06781359CI-TRIAL-00122757FIL_PlaLyrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is an observational, multicenter, international and retrospective study, that aims to collect data on clinical and pathological characteristics, treatment regimens, outcome, and prognostic factors (clinical, biomarkers and/or radio-metabolic) in patients affected by PBL.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Plasmablastic Lymphoma | Plasmablastic Lymphoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Plasmablastic lymphoma patients
- description
- Patients with diagnosis (histologically confirmed) of plasmablastic lymphoma (PBL) between Jan 1st 2000 and Dec 31st 2022
Primary outcomes (1)
- measure
- Overall Survival (OS)
- timeFrame
- 36 months
- description
- OS is defined as the time from the diagnosis to death for any cause or last clinical contact for censored patients.
Secondary outcomes (11)
- measure
- ECOG-PS
- timeFrame
- 36 months
- description
- Proportion of Performance Status: from 0 (fully active) to 4 (Completely disabled)
- measure
- Ann Arbor Stage
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of plasmablastic lymphoma (PBL) between Jan 1st 2000, and Dec 31st 2022 * Histologically confirmed plasmablastic lymphoma (PBL) diagnosis according to local pathological report * Age \> 18 years old * Availability of complete medical records * Availability of histopathological material requested by the study Exclusion Criteria: * Any other histology than PBL * Lack of complete medical records * Lack of histopathological material requested by the study
References
Publications (0)
Data not yet available
No reference posted for this study.